AVITA Medical, Inc. (RCEL) Cash & Current Investments (2018 - 2026)

AVITA Medical (RCEL) has reported Cash & Current Investments for 9 consecutive years, with $11.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments fell 29.03% year-over-year to $11.1 million; the trailing twelve-month figure through Jun 2026 stood at $11.1 million (down 29.03% YoY), and the FY2025 full-year result was $18.2 million, down 49.32% from the prior year.
• Cash & Current Investments slipped to $11.1 million in Q2 2026 per RCEL's latest filing, from $18.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $89.1 million in Q4 2023 and bottomed at $11.1 million in Q2 2026.
• Historically, Cash & Current Investments has averaged $54.0 million across 5 years, with a median of $60.1 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments gained 12.24% in 2023, then tumbled 70.97% in 2025.
• Over 5 years, Cash & Current Investments stood at $79.3 million in 2022, then rose by 12.24% to $89.1 million in 2023, then plunged by 59.71% to $35.9 million in 2024, then sank by 49.32% to $18.2 million in 2025, then plunged by 38.77% to $11.1 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $11.1 million, $18.2 million, and $23.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.